Phathom Pharmaceuticals (PHAT) Debt Metrics

Price: $6.325
Market Cap: $440.45M
Avg Volume: 1.12M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.636
52W Range: $4.07-19.71
Website: Phathom Pharmaceuticals

How much debt does Phathom Pharmaceuticals have?

According to Phathom Pharmaceuticals's latest annual financial reports, the company's debt profile is as follows:

Total Debt and Liabilities

Phathom Pharmaceuticals's total debt stands at $501.00K. This is broken down into:

  • Long-term debt: $-
  • Short-term debt: $1.00M

The company's net debt, which accounts for cash and cash equivalents, is $-296.76M. In terms of overall financial obligations, Phathom Pharmaceuticals's total liabilities amount to $631.90M.

Debt Ratios and Metrics

To better understand Phathom Pharmaceuticals's debt position, we can look at several key ratios:

  • Debt to Equity Ratio: 0.00 - this indicates the proportion of equity and debt the company uses to finance its assets.
  • Debt Ratio: 0.13% - this shows the proportion of a company's assets that are financed through debt.
  • Interest Coverage Ratio: -3.85 - this measures how easily a company can pay interest on its outstanding debt.
  • Long-term Debt to Capitalization: 0.00% - this shows the proportion of long-term debt in the company's capital structure.
  • Total Debt to Capitalization: -0.20% - this indicates the total debt in the company's capital structure.

These metrics provide insight into Phathom Pharmaceuticals's financial leverage and its ability to meet financial obligations. For a comprehensive understanding of the company's financial health, it's important to consider these debt metrics alongside other financial indicators and industry benchmarks.

Total Debt

$501.00K

Long-term Debt

$-

Short-term Debt

$1.00M

Net Debt

$-296.76M

Total Liabilities

$631.90M

Interest Coverage

-3.85

Debt to Equity Ratio

0.00

Debt Ratio

0.13%

Phathom Pharmaceuticals Historical Debt Metrics
Total Debt
Long-term Debt
Short-term Debt
Net Debt
$200.00M$200.00M$100.00M$100.00M$0.00$0.00-$100.00M-$100.00M-$200.00M-$200.00M-$300.00M-$300.00MDebt Metrics201920192020202020212021202220222023202320242024

Phathom Pharmaceuticals Historical Debt

The table below shows various debt metrics for each year, with the latest data available for the last fiscal year 2024.

Year Total Debt Long-term Debt Short-term Debt Net Debt Total Liabilities Debt to Equity Debt Ratio Interest Coverage Long-term Debt to Capitalization Total Debt to Capitalization
2024 $501.00K $- $1.00M $-296.76M $631.90M 0.00 0.13% -3.85 0.00% -0.20%
2023 $139.03M $138.30M $726.00K $-242.36M $486.60M -1.91 33.59% -3.99 211.79% 209.79%
2022 $97.07M $96.36M $1.42M $-58.31M $239.62M -1.30 58.90% -6.32 465.84% 436.15%
2021 $91.34M $90.85M $974.00K $-91.92M $117.28M 1.27 48.22% -19.90 55.41% 55.87%
2020 $49.02M $41.19M $8.30M $-238.48M $100.84M 0.25 16.61% -27.43 16.94% 20.15%
2019 $23.57M $23.41M $322.00K $-220.19M $29.22M 0.10 9.17% -25.43 9.08% 9.37%
2018 $1.95M $- $1.95M $1.07M $2.19M -1.52 216.19% -94.23 0.00% 293.67%

Related Metrics

Explore detailed financial metrics and analysis for PHAT.